TY  - JOUR 
AU  - Larraga, Jaime
AU  - Rodríguez-Martín, Daniel
AU  - Alonso, Ana
AU  - Loayza, Francisco J.
AU  - Rojas, José M.
AU  - Ruiz-García, Silvia
AU  - Louloudes-Lázaro, Andrés
AU  - Carlón, Ana B.
AU  - Sánchez-Cordón, Pedro J.
AU  - Nogales-Altozano, Pablo
AU  - Redondo, Natalia
AU  - Manzano, Miguel
AU  - Lozano, Daniel
AU  - Montoya, María
AU  - Vallet-Regí, María
AU  - Martín, Verónica
AU  - Sevilla, Noemí
AU  - Larraga, Vicente
AU  - Alcolea, Pedro José
AU  - Palomero Labajos, Jesús
PY  - 2022
UR  - http://hdl.handle.net/10366/154088
AB  - [EN] SARS-CoV-2 vaccines currently in use have contributed to controlling the
COVID-19 pandemic. Notwithstanding, the high mutation rate, fundamentally
in the spike glycoprotein (S), is causing the emergence of new variants. Solely
utilizing this...
LA  - eng
PB  - Board
KW  - SARS-CoV-2
KW  - DNA vaccine
KW  - S protein
KW  - N protein
KW  - Mouse model
KW  - pPAL
KW  - Furin
KW  - Furin
KW  - SARS Virus
KW  - DNA
TI  - Non-replicative antibiotic resistance-free DNA vaccine encoding S and N proteins induces full protection in mice against SARS-CoV-2
DO  - 10.3389/FIMMU.2022.1023255
T2  - Frontiers in Immunology
VL  - 13
M2  - 1
ER  -